Nano-X Imaging enters its next earnings report under a cloud that has little to do with quarterly comparisons and everything to do with survival math. When management last spoke to investors, it did something it had never done before: it pulled its own full-year revenue target of more than $35 million, a number it had set and reaffirmed just one quarter earlier, and disclosed explicit going-concern doubt about its ability to fund operations for the next twelve months. That combination changes what this report needs to prove. It is no longer primarily about whether teleradiology or AI software revenue grew another few hundred thousand dollars sequentially. It is about whether the company has stabilized its cash position and whether the commercial green shoots it touted are durable enough to matter before dilution reshapes the shareholder base further. The consensus EPS figure supplied for this period is not meaningful on its own, since the prior quarter posted a $0.20 per share loss against a $0.23 loss a year earlier, and any percentage growth calculation off such small negative bases tends to produce distorted, headline-grabbing numbers rather than useful signal. Revenue consensus was not disclosed, so investors are left leaning heavily on the qualitative record from the last call. There is no updated formal guidance to compare against, in part because management explicitly abandoned the practice of issuing annual revenue targets after the last miss, which removes a traditional anchor for judging this quarter's results. The prior call's real substance was a tension between improving underlying trends and a much more defensive corporate posture. Teleradiology revenue had more than doubled since the US-Arad acquisition, AI and software revenue jumped meaningfully with gross margins in the 80s, and RadNet, the largest outpatient imaging operator in the country, had moved into sustained commercial use of the ARC system. Those are legitimate proof points that recurring, higher-margin revenue lines are gaining traction. But they were overshadowed by ARC hardware revenue that remains stuck in the low hundreds of thousands of dollars, nowhere near the ramp implied by prior commentary, and by cash that fell from $60 million to roughly $27 million net of a short-term loan in a single quarter. This report needs to show that the promised opex reduction from Israeli headcount cuts and the Korea restructuring is actually showing up in the burn rate, and that management has either secured financing or narrowed its funding gap since the going-concern disclosure. Investors should also watch for concrete progress on the 21-site Nanox Imaging Network, additional RadNet site expansion, and whether AI break-even timing holds at early 2027 or slips again, since repeated slippage was a recurring theme in the last call. Sentiment context suggests the market has grown more cautious rather than less, with bullish readings on Earnings Whisper dropping to 6.4% from 11.4% ahead of the prior report. That skepticism lines up with price action, as the stock has fallen nearly 30% since the last earnings release while the S&P 500 gained almost 4%, a stark underperformance that reflects the going-concern disclosure more than any single revenue miss. Shares now trade well below their 200-day moving average of $2.19 and sit near the low end of a post-earnings range between $0.73 and $1.44, a much narrower and lower band than the $1.50 to $2.44 range of the prior quarter. The central question heading into this report is whether Nano-X can demonstrate that its financing situation is stabilizing and its recurring revenue momentum is real, or whether the going-concern narrative continues to overwhelm the commercial story management is trying to tell.